Dear Editor, Leclercia adecarboxylata, which is found widely in nature, was first isolated from drinking water and initially described as Escherichia adecarboxylata by Leclerc in 1962 [1, 2] . The species was renamed after phenotypic and genotypic studies by Tamura et al. [3] in 1986. It is a motile, facultative-anaerobic, Gramnegative rod of Enterobacteriaceae family [4] . Several L. adecarboxylata can be misidentified as Escherichia coli, because L. adecarboxylata and E. coli share many biochemical properties [2, 4] . In this report, we aimed to compare two identification systems, VITEK ® MS (bioMérieux, France) and VITEK ® 2 Compact (bioMérieux), and to evaluate L. adecarboxylata with colony color on chromogenic CPSE media (bioMérieux) to differentiate L. adecarboxylata from E. coli, using two clinical isolates definitively identified by sequencing of 16S rRNA. Table I shows general information of two L. adecarboxylata cases. Urine and pus samples were inoculated on 5% sheep blood agar and MacConkey agar. Both VITEK ® 2 Compact (bioMérieux) automatic identification system and matrix-assisted laser desorption/ionization time of flight mass spectrometry-based † A part of this study was presented as a poster at the 37th Turkish Microbiology Congress, November 16-20, 2016, Antalya, Turkey. *Corresponding author; E-mail: banusancak@yahoo.com VITEK ® MS system identified three isolates as L. adecarboxylata, Staphylococcus epidermidis, and Enterococcus faecalis for case 1, and three isolates as L. adecarboxylata, Enterobacter cloacae, and E. faecalis for case 2. The identification of L. adecarboxylata was, additionally, confirmed by 16S rRNA gene sequencing.
L. adecarboxylata grew as non-hemolytic colonies on blood agar and lactose-negative (case 1) and lactose-positive (case 2) colonies on MacConkey's agar from both of the samples. Pure colonies of L. adecarboxylata isolates were also inoculated on chromogenic CPSE media. They grew on the chromogenic medium forming the turquoise green colonies, whereas E. coli isolates usually produced pink colonies ( Figure 1 ). The antibiotic susceptibility testing was done using VITEK ® 2 Compact (bioMérieux). The isolate of case 2 was found susceptible to all the antimicrobials tested, including ampicillin, cefoxitin, ceftazidime, ceftriaxone, amikacin, gentamicin, ciprofloxacin, trimethoprim-sulfamethoxazole (TMP/SMX), imipenem, meropenem, ertapenem, piperacillin/ tazobactam, and fosfomisin. The isolate of case 1 was found susceptible to all the antimicrobials tested except fosfomycin and TMP/SMX.
L. adecarboxylata has been reported as an uncommon cause of sepsis, septic arthritis, peritonitis, and diarrhea, and usually isolated as an opportunistic pure pathogen from clinical specimens including blood, stool, sputum, urine, peritoneal fluid, and pus in reported cases of immunocompromised patients or patients with underlying medical conditions [2, 4] . In the immunocompetent patients, L. adecarboxylata is usually found as a part of polymicrobial infections [4] . This report shows that both of the patients had underlying medical conditions and demonstrated polymicrobial cultures. The accurate identification of L. adecarboxylata isolates from clinical specimens is very important for diagnosis, treatment, and epidemiological information. Clinical microbiology laboratories play a key role in the accurate identification of microorganisms, using conventional methods, molecular tests, and automated systems. Especially technological systems, such as automated identification systems and mass spectrometry, may allow laboratories to identify unusual organisms rapidly and accurately [5] . In our report, we used VITEK ® MS and VITEK ® 2 Compact. Both identification systems accurately identified L. adecarboxylata isolates. In literature, there are many reports that L. adecarboxylata was identified by automated identification systems and mass spectrometry [4, [6] [7] [8] [9] [10] . However, only two of these reports were confirmed by 16S rRNA gene sequencing, like our report [9, 10] .
Technological systems are quite expensive and may not be available in smaller laboratories [5] . L. adecarboxylata can be misidentified as E. coli, because L. adecarboxylata is phenotypically and biochemically very similar to E. coli that routine conventional methods may not reliably differentiate them from each other [2] . Chromogenic CPSE media might be used if automated systems are not available for identification of L. adecarboxylata. Figure 1 shows that it can provide preliminary information that can be used to differentiate L. adecarboxylata from E. coli.
Stock et al. [2] reported that L. adecarboxylata is naturally resistant to erythromycin, roxithromycin, clarithromycin, streptogramins, linezolid, penicillin G, oxacillin, ketolides, lincosamides, glycopeptides, rifampicin, fusidic acid, and fosfomycin. They also stated that fosfomycin resistance might be useful to differentiate L. adecarboxylata and E. coli [2] . Despite this knowledge, there were no information about fosfomycin resistance, or it was not tested in most of the studies [2] [3] [4] [6] [7] [8] [9] [10] . One of our isolates was resistant to fosfomycin, whereas the other was susceptible.
In conclusion, L. adecarboxylata is rarely isolated from clinical specimens in literature, but usage of new identification systems in clinical microbiology laboratories would increase the prevalence of rare microorganisms, such as L. adecarboxylata. Besides, in laboratories where automated systems are not available, chromogenic agar may be useful to differentiate L. adecarboxylata from E. coli. Additional studies are needed to confirm this information.
